A notable finding in this study is the capacity of ephrinB2-Fc-His and Fc-TNYL-RAW-GS to decrease local tumor growth and the incidence of lung metastases in a preclinical model of HNSCC. This evidence concerns the gene EFNB2 and head and neck squamous cell carcinoma.